Chief editor

Prof. M. Drent, MD PhD


Marjolein Drent is a pulmonologist at the ILD Center of Excellence of the St. Antonius Hospital, Nieuwegein, The Netherlands. Furthermore, she is appointed as professor of interstitial lung diseases (ild) at the Department of Pharmacology and Toxicology of the Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, NL. Her oration was entitled: ‘Breathtaking inspirations…’ ( In 1993, she completed her thesis entitled ‘Diagnostic value of bronchoalveolar lavage in interstitial lung diseases.’ From 1994 till January 2012 she worked at the Department of Respiratory Medicine of the Maastricht University Medical Centre (MUMC), NL. From 2012 till 2015 she was head of the ild care expertise team, Hospital Gelderse Vallei (ZGV), Ede, NL. Currently, she is the manager of ild care consultancy, an international network offering information how to manage patients with ild. Her research focuses on ild, translational medicine and e-health. She is a reviewer of many international journals and has co-authored over 300 papers and book chapters. She is chief editor of Current Opinion in Pulmonary Medicine and associate editor of Sarcoidosis, Vasculitis and Diffuse Lung Diseases. Furthermore, she is concerned with several educational assignments and organisation of postgraduate courses. She organized the second WASOGBAL meeting in June 2011 in Maastricht, as well as a patient symposium (15-06-2011). She has been involved with the European BAL Group since 1990 and was chair of ERS Assembly Diffuse Parenchymal Lung Diseases 1.5. She is president of the World Association of Sarcoidosis and other Granulomatous Disorders (WASOG).

She is the founder and chair of the ild care (interstitial lung diseases including sarcoidosis and lung diseases related to occupation and environment management and research) foundation (please visit: and  She is a honorary member of the SBN (Dutch Sarcoidosis Society) and founder and a member of the advisory board of the Dutch Pulmonary Fibrosis Society. In 2007 she received the Novartis Pulmonology award. This was awarded by a national jury because of her dedication to achieve improvement of the quality of life of patients. She was selected as the leading physician of 2011 as well as 2012 by her colleague Dutch pulmonary doctors (MEDNET). In 2012 she was nominated for the ‘World Sarcoidosis Person of the Year Award’ for her tiredless research work in defining the psychological burden faced by patients and their families. Dublin, Ireland. 15-11-12.This award is selected by patients of the Irish Sarcoidosis Support Network (ISarc). She is ambassador for Compassion for Care ( Since 2015 she is a member of the Foundation for Sarcoidosis Research (FSR: Scientific Advisory Board (SAB).


Publications: pubmed


website: ild care foundation